[3P-663] Application of a protein kinase Cα (PKCα)-specific peptide substrate to development of cancer diagnostic tool

^○JeongHun Kang¹, Takahito Kawano², Masaharu Murata², Junichi Inokuchi³, Masatoshi Eto^2,3 (1.Div. of Biopharm. Pharmacol., NCVC Res. Inst., 2.Adv. Innovation Center, Univ. of Kyushu, 3.Dept. of Urol., Grad. Sch. of Med., Univ. of Kyushu)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-664] Optimal structure of lentiviral vectors for gene therapy

^○Izumi Maki, Yasunori Amaishi, Ryosuke Nagata, Sachiko Okamoto, Junichi Mineno (Technology Development Center, TaKaRa Bio Inc.)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-665] Evaluation of cellular responses to the anti-cancer therapies by in vivo cell-imaging with micro-endoscopy

^○Toshiyuki Goto¹, Sally Danno¹, Masayuki Nakano¹, Asako SakaueSawano², Ryoko Ando², Atsushi Miyawaki^2,3, Ichiro Nakahara¹, Yosky Kataoka^1,4, Kazuo Funabiki^1,5 (1.Laboratory for Cellular Function Imaging, RIKEN BDR, 2.Laboratory for Cell Function Dynamics, RIKEN CBS, 3.Biotechnological Optics Research Team, RIKEN RAP, 4.Multi-Modal Microstructure Analysis Unit, RIKEN BZP, 5.Foundation for Biomedical Research and Innovation)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-666] C. elegans as a biosensor for specific pancreatic cancer detection using urine

^○Yoshihisa Ueno, Eric di Luccio, Toshimi Sugimoto, Takaaki Hirotsu (Hirotsu Bioscience Inc.)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-667] Tumor-specific immune activation mechanism in radiotherapy using alpha-emitting radionuclides

^○Koki Mayusumi¹, Kazuya Kabayama^1,2,3, Xuhao Huang¹, Kazuko Kaneda^2,3, Atsushi Toyoshima^2,3, Koichi Fukase^1,2,3 (1.Dept. of Chem., Grad. Sch. of Sci., Osaka Univ., 2.FRC, Grad. Sch. of Sci., Osaka Univ., 3.Inst. for Radiation Sciences, Osaka Univ.)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-668] Interactions between eIF4B and CAMK2G promote proliferation of malignant cells in myelofibrosis.

^○Ken Sasaki¹, Tadayuki Ogawa², Yosuke Masamoto¹, Hideaki Mizuno¹, Mineo Kurokawa¹ (1.Dept. of Hematol and Oncol, Univ of Tokyo, 2.Advanced Medical Research Center, Univ of Dokkyo)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-669] Estimation of curative effects in stereotactic body radiotherapy for lung cancer based on a theoretical model considering cancer stem-like cells for predicting radiosensitivity

^○Ryo Saga¹, Yusuke Matsuya², Hikari Sato¹, Kazuki Hasegawa¹, Hideki Obara³, Fumio Komai³, Hironori Yoshino¹, Hiroyuki Date², Masahiko Aoki⁴, Yoichiro Hosokawa¹ (1.Dept. of Radiat. Sci., Grad. Sch. of Health Sci., Hirosaki Univ., 2.Fac. of Health Sci., Hokkaido Univ., 3.Dept. of Radiol., Div. of Med. Technol., Hirosaki Univ. Hosp., 4.Dept. of Radiat. Oncol., Grad. Sch. of Med., Hirosaki Univ.)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-670] Role of stromal fibroblasts on osteoclastogenesis in ameloblastoma

^○Shohei Yoshimoto, Kazuhiko Okamura (Sect. of Pathol., Fukuoka Dent. Col.)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-671] The Role of p16-expressing Stromal Cells in Tumor Microenvironment

^○Yue Zhang, TehWei Wang, Makoto Nakanishi (IMSUT)

The 45th Annual Meeting of the Molecular Biology Society of Japan

[3P-672] Synthesis and evaluation of XIAP inhibitors designed by structural optimization of lead compounds using AI technology

^○Koutaro Sasaki¹, Kouji Kuramochi², Atsushi Yoshimori³, Ryoko Takasawa^4,1 (1.Dept. Pharm. Sci., Grad. Sch. Pharm. Sci., Tokyo Univ. Sci., 2.Facul. Sci. Tech., Tokyo Univ. Sci., 3.ITM, Inc., 4.Facul. Pharm. Sci., Tokyo Univ. Sci.)

The 45th Annual Meeting of the Molecular Biology Society of Japan